AC Immune SA
ACIU
$1.55
-$0.0402-2.53%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -235.75% | 137.11% | -34.41% | -7.94% | 72.50% |
| Total Depreciation and Amortization | -3.89% | -1.61% | 0.70% | 3.23% | -0.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -144.58% | -243.74% | 432.74% | -85.67% | 153.52% |
| Change in Net Operating Assets | 254.20% | -4,257.27% | 18,413.93% | 1,405.81% | -4,017.76% |
| Cash from Operations | 136.95% | -8.59% | 614.26% | 106.45% | -1.11% |
| Capital Expenditure | 45.33% | 38.36% | 56.38% | -31.79% | -340.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -116.07% | -139.17% | -1,405.96% | -157.38% | 409.73% |
| Cash from Investing | -116.57% | -145.15% | -1,361.97% | -158.26% | 410.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -23.02% | -23.74% | -28.15% | -23.70% | 2.80% |
| Issuance of Common Stock | -- | -- | -93.44% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -242.86% | -8,616.67% | -- |
| Cash from Financing | -100.48% | -139.43% | -103.22% | -416.34% | 29,631.49% |
| Foreign Exchange rate Adjustments | 226.66% | -5,486.25% | -3,531.14% | 18,526.85% | -429.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -91.65% | -141.97% | 68.94% | -187.97% | 491.88% |
